SCHEMBL1377693

SCHEMBL1377693

c1cc(OCCN2CCCC2)cc(-c2onc3sccc23)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.55
BACE1 P56817 2/20 0.54
HRH3 Q9Y5N1 5/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAP4K4 O95819 2/20 0.45
GAK O14976 1/20 0.43
DYRK3 O43781 1/20 0.43
JAK2 O60674 1/20 0.43
PRKD3 O94806 1/20 0.43
NQO2 P16083 1/20 0.43
CSNK2A2 P19784 1/20 0.43
FECH P22830 1/20 0.43
JAK1 P23458 1/20 0.43
TYK2 P29597 1/20 0.43
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
CSNK1A1 P48729 1/20 0.43
CSNK1D P48730 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686431 0.99 BACE1 (0.56) LTA4HBACE1HRH3KDM4EALDH1A1
SCHEMBL7635672 0.94 HRH3 (0.52) LTA4HBACE1HRH3KDM4EALDH1A1
SCHEMBL1376907 0.86 HTR7 (0.40) LTA4HBACE1HRH3KDM4EALDH1A1
SCHEMBL1376598 0.83 DRD2 (0.47) HRH3
SCHEMBL1377207 0.83 DRD3 (0.53) HRH3
SCHEMBL7633768 0.82 MAOA (0.37) KDM4ESMN1; SMN2
SCHEMBL7638803 0.82 CYP1A2 (0.38) KDM4ESMN1; SMN2ADORA2A
SCHEMBL7631973 0.81 MAOA (0.38) KDM4ESMN1; SMN2
SCHEMBL7632638 0.81 L3MBTL1 (0.47)
SCHEMBL1379788 0.80 DRD2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4717306-B2 2011-07-06 JP claimed
JP-2003509431-A 2003-03-11 JP claimed
EP-1216249-A2 THIENOISOXAZOLE PHENOXY UNSUBSTITUTED ETHYL AND PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP claimed
WO-2001019832-A2 THIENOISOXAZOLE PHENOXY UNSUBSTITUTED ETHYL AND PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-1216249-A2 THIENOISOXAZOLE PHENOXY UNSUBSTITUTED ETHYL AND PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP disclosed
WO-2001019832-A2 THIENOISOXAZOLE PHENOXY UNSUBSTITUTED ETHYL AND PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed